Sevaro Health Raises $39M to Expand AI-Powered Virtual Neurology Platform

Sevaro Health, a virtual neurological care specialist, has closed a $39 million Series B funding round led by Valtruis and Intermountain Ventures, with participation from existing investors. The capital injection will fuel the company's expansion of its AI-driven platform that addresses critical staffing shortages and rising patient demand in hospital systems nationwide.

The centerpiece of Sevaro's offering is Synapse AI, a platform designed to seamlessly connect hospital teams with virtual specialists throughout the entire patient journey. The technology distinguishes itself by providing comprehensive coverage across the full continuum of care—from ambulance transport to ambulatory settings—including virtual neurology clinics, rehabilitation expertise, and coordinated care solutions. This end-to-end approach positions Sevaro as one of the first companies in the industry to offer such comprehensive virtual specialty coverage.

For hospital partners, Synapse AI functions as an extension of their existing workforce rather than a replacement. The platform prevents coverage gaps, reduces physician burnout, and ensures timely backup coverage through seamless workflow automation. While the company initially focused on neurological care, its proven model is now expanding into additional specialties including cardiology, infectious disease, behavioral health, and surgery.

Early results from hospital partnerships demonstrate significant operational and financial benefits. One health system achieved savings exceeding $4 million in its first year by increasing access to virtual neurology care and reducing unnecessary hospital transfers. Partners report an average response time of just 25 seconds to reach a neurologist, along with increased referrals and improved provider satisfaction scores.

The new funding will enable Sevaro to accelerate innovation within its platform, deepen integrations with hospital systems, and expand its hybrid workforce model. These investments come at a critical time as hospitals nationwide grapple with specialist shortages and increasing patient volumes that strain traditional care delivery models.

"This funding validates what we've believed from day one, that hospitals deserve a model where quality and financial performance go hand in hand," said Dr. Rajiv Narula, Founder and CEO of Sevaro Health. "Synapse AI isn't just a solution for coverage, it's our commitment to building the future of specialty care where physicians are proud to practice, and every patient in the world receives the care they deserve."

The Series B round represents growing investor confidence in virtual specialty care solutions that can demonstrate measurable clinical and financial outcomes while addressing healthcare's most pressing workforce challenges.

Click here for the original news story.